Elevance Health (NYSE:ELV – Get Free Report) had its price objective lowered by stock analysts at Wells Fargo & Company from $483.00 to $478.00 in a report issued on Tuesday,Benzinga reports. The ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Health-care companies rose sharply amid strong earnings.

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early ...

(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted ...

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.

Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services has sparked debate due to his previously earned ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating ...